AngioDynamics, Inc. (ANGO) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Angiodynamics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.117 Good morning and welcome to the AngioDynamics Fiscal Year 2025 Fourth Quarter Earnings 00:00:04.117 -- 00:00:08.103 Call. At this time, all participants are in listen-only mode. 00:00:08.103 -- 00:00:11.989 The question and answer session will follow the formal presentation. 00:00:11.989 -- 00:00:15.434 As a reminder, this conference call is being recorded. 00:00:15.434 -- 00:00:20.581 The news release detailing AngioDynamics' Fiscal Year 2025 Fourth Quarter and Full 00:00:20.581 -- 00:00:24.707 Year results crossed the wire earlier this morning and is available on the company's 00:00:24.707 -- 00:00:26.350 website. 00:00:26.350 -- 00:00:30.452 This conference call is also being broadcast live over the Internet at the Investors 00:00:30.452 -- 00:00:34.514 section of the company's website at www.angiodynamics.com. 00:00:36.437 -- 00:00:40.281 A webcast replay of the call will be available at the same site approximately one hour 00:00:40.281 -- 00:00:43.064 after the end of today's call. 00:00:43.064 -- 00:00:46.607 Before we begin, I'd like to caution listeners that during the course of this conference 00:00:46.607 -- 00:00:50.471 call, the company will make projections or forward-looking statements regarding future 00:00:50.471 -- 00:00:55.575 events, including statements about expected revenue, adjusted earnings and gross margins 00:00:55.575 -- 00:00:57.758 for fiscal year 2026, 00:00:57.758 -- 00:01:00.427 as well as trends that may continue. 00:01:00.427 -- 00:01:05.074 Management encourages you to review the company's past and future filings with the SEC, 00:01:05.074 -- 00:01:10.581 including, without limitation, the company's forms 10-Q and 10-K, which identify 00:01:10.581 -- 00:01:15.128 specific factors that may cause th...